Integrating frailty interventions into existing care models: a comprehensive approach to enhancing patient outcomes in chronic disease management by Izabella Uchmanowicz, Izabella Uchmanowicz, Kenneth M. Faulkner, Paolo Iovino, Adrian Kwaśny, Stanisław Surma, Camilla Elena Magi, Grzegorz K. Jakubiak, Yari Longobucco, Dawid Janczak, Alina Rak-Pasikowska, Michał Czapla, Michał Czapla, Bartosz Uchmanowicz

Subjects: “…frailty syndrome…”
Get full text

How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients? by Bartosz Uchmanowicz, Anna Chudiak, Izabella Uchmanowicz, Grzegorz Mazur

“…Treatment noncompliance and lack of cooperation stem from numerous problems of older age, including frailty syndrome. Objective. To evaluate the effect of frailty syndrome on treatment compliance in older patients with hypertension. …”
Get full text

Prevalence and Risk Factors of Urinary Incontinence in Frail Elderly Females by Walaa W. Aly, Hala S. Sweed, Nora A. Mossad, Mohammad F. Tolba

“…Urinary incontinence (UI) is an important geriatric health problem, and it is linked to frailty syndrome. We had conducted a study to detect the prevalence and risk factors of UI and its effect on quality of life (QOL) among frail elderly females living in Cairo, Egypt. …”
Get full text

Effects of a 12-Week Exercise Training Program on Physical Function in Institutionalized Frail Elderly by Cristiane Batisti Ferreira, Pâmela dos Santos Teixeira, Geiane Alves dos Santos, Athila Teles Dantas Maya, Paula Americano do Brasil, Vinícius Carolino Souza, Cláudio Córdova, Aparecido Pimentel Ferreira, Ricardo Moreno Lima, Otávio de Toledo Nóbrega

“…However, longevity is usually accompanied by problems such as the loss of functional capacity, cognitive decline, frailty syndrome, and deterioration in anthropometric parameters, particularly among those living in long-term care facilities. …”
Get full text

The Use of SGLT-2 Inhibitors and GLP-1RA in Frail Older People with Diabetes: A Personalised Approach Is Required by Alan J. Sinclair, Ahmed H. Abdelhafiz

“…<b>Background:</b> Frailty is an increasingly recognised complication of diabetes in older people and should be taken into consideration in management plans, including the use of the new therapies of sodium glucose cotransporter-2 (SGLT-2) inhibitors and glucagon like peptide-1 receptor agonists (GLP-1RA). The frailty syndrome appears to span across a spectrum, from a sarcopenic obese phenotype at one end, characterised by obesity, insulin resistance, and prevalent cardiovascular risk factors, to an anorexic malnourished phenotype at the other end, characterised by significant weight loss, reduced insulin resistance, and less prevalent cardiovascular risk factors. …”
Get full text